SCI
-
Hospitals
MCRA Assists Cartiva, Inc. with Obtaining FDA PMA Approval for the Company’s Synthetic Cartilage Implant (SCI)
WASHINGTON, July 20, 2016 /PRNewswire-USNewswire/ — Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA) announced today its role in the successful Premarket Approval (PMA) application…
Read More » -
Spine
Q&A: The Lesser-known Maladies of Spinal Cord Injuries
By Michelle Taylor Last month, David Sharp and his fellow colleagues at the Albert Einstein College of Medicine, Bronx, N.Y.,…
Read More » -
Spine
Neuromodulation stem cells studied as new treatments for patients with spinal cord injuries
An acute spinal cord injury is a sudden injury that results in a bruise, partial injury or complete injury of…
Read More » -
Spine
U.S. Spinal Cord Injury Patient Documenting His Stem Cell Plus Epidural Stimulation Treatment
BANGKOK, July 24, 2015 /PRNewswire/ — Quadriplegic Jack Pearce is set to undergo a new medical procedure that he is hoping may transform his…
Read More » -
Extremities
Cartiva Announces Positive Final Data from its Cartiva SCI Pivotal Trial for Great Toe Arthritis
ALPHARETTA, Ga.–(BUSINESS WIRE)–Cartiva, Inc., a developer of innovative solutions for the treatment of cartilage damage, osteoarthritis and other musculoskeletal conditions,…
Read More » -
Spine
StemCells, Inc. Completes Enrollment of First Cohort in Phase II Pathway Study for Cervical Spinal Cord Injury
NEWARK, Calif., Apr 16, 2015 (GLOBE NEWSWIRE via COMTEX) — StemCells, Inc. STEM, +1.59% a leading stem cell company developing…
Read More »